Is subendocardial or transmural late gadolinium enhancement able to differentiate between dcm and icm on cardiac mri?
© Noguchi et al; licensee BioMed Central Ltd. 2010
Published: 21 January 2010
In ischemic cardiomyopathy (ICM), subendocardial and transmural late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) are useful findings to differentiate from dilated cardiomyopathy (DCM). The previous studies emphasize that all ICM shows subendocardial or transmural LGE based on fibrosis of infracted myocardium, however ICM with no LGE such as hibernated myocardium caused low EF and LV dilatation as well as DCM also exists.
The purpose of our study is to evaluate LGE pattern in patients with low EF and LV dilatation, and to clarify the feasibility for classifying ICM from DCM applied to LGE pattern.
Ninety patients with LVEF < 40% and LVDd >60 mm on CMR were enrolled in the study (71 male, mean age 52 y.o). Secondary cardiomyopathy and previously diagnosed ischemic heart disease were excluded. All patients underwent coronary angiography (CAG), on the basis of which we classified into DCM (n = 82) and ICM (n = 8). ICM was defined as improvement of LVEF and LV dilatation after revascularization. Whole heart was divided into 17-segments according to the AHA recommendation. LGE pattern; such as localization (5 patterns: subendocardial, transmural, mid-wall, epicardial, and mixed) , distribution (3 types: patchy, linear: greater than 50% of a flabellate segment and within 50% of the extent, and diffuse) , and extent (5 point scales: 0 = none, 1 = 1% to 25%, 2 = 26% to 50%, 3 = 51% to 75%, and 4 = 76% to 100% of LV wall thickness of LGE) were assessed.
LGE pattern of CMR is not feasible findings for classifying ICM from DCM precisely in patients with both LV dilatation and low EF. On the other hand, the mid-wall LGE was also certified as definitive findings in only DCM.
This article is published under license to BioMed Central Ltd.